CSIMarket
 


Genocea Biosciences Inc   (GNCA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

GNCA's Operating Income Growth by Quarter and Year

Genocea Biosciences Inc 's Operating Income results by quarter and year




GNCA Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -9.86 -2.85 -10.39
III Quarter September - -9.58 -10.46 -16.50
II Quarter June - -10.07 -9.79 -15.00
I Quarter March -13.38 -9.48 -10.38 -13.38
FY   -13.38 -38.99 -33.48 -55.27



GNCA Operating Income first quarter 2020 Y/Y Growth Comment
Genocea Biosciences Inc in the first quarter recorded Operating Loss of $ -13.38 millions.

According to the results reported in the first quarter, Genocea Biosciences Inc achieved the best Operating Income growth in Biotechnology & Drugs industry. While Genocea Biosciences Inc ' s Operating Income no change of % ranks overall at the positon no. in the first quarter.

Explain Operating Income growth


GNCA Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Genocea Biosciences Inc 's first quarter 2020 Operating Income $ -13.38 millions GNCA's Income Statement
Genocea Biosciences Inc 's first quarter 2019 Operating Income $ -9.48 millions Quarterly GNCA's Income Statement
New: More GNCA's historic Operating Income Growth >>


GNCA Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Genocea Biosciences Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GNCA's I. Quarter Q/Q Operating Income Comment
Recent results of -13.38 millions by Genocea Biosciences Inc appear even less good compare to the -9.86 millions a quarter before.

Within Biotechnology & Drugs industry Genocea Biosciences Inc achieved highest sequential Operating Income growth. While Genocea Biosciences Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GNCA's I. Quarter Q/Q Operating Income Comment
Current results of -13.38 millions by Genocea Biosciences Inc appear even less good compare to the Operating Loss -9.86 millions in the previous quarter.

Within Biotechnology & Drugs industry Genocea Biosciences Inc achieved highest sequential Operating Income growth. While Genocea Biosciences Inc 's Operating Income growth quarter on quarter, overall rank is .


Genocea Biosciences Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2017)
Cumulative Operating Income 12 Months Ending $ -42.89 $ -38.99 $ -31.98 $ -32.85 $ -52.19
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Genocea Biosciences Inc ' has realized cumulative trailing twelve months Operating Loss of $ -43 millions in the Mar 31 2020 period.
The results are getting worse as the cumulative Operating Loss is getting bigger from $ -38.99 millions in the twelve months ending a quarter before and $ -9.86 millions for the twelve months ending in the quarter Mar 31 2017 Renata Inácio Ramos wrote.

Genocea Biosciences Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Genocea Biosciences Inc ' has realized cumulative trailing twelve months Operating Loss of $ -43 millions in the Mar 31 2020 period.
The results are detiriorating as the cumulative Operating Loss is becoming larger from $ -38.99 millions in the twelve months ending a quarter before and $ -9.86 millions from the TTM period ending Mar 31 2017 Renata Inácio Ramos told.

Genocea Biosciences Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
GNCA's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for GNCA's Competitors
Operating Income Growth for Genocea Biosciences Inc 's Suppliers
Operating Income Growth for GNCA's Customers

You may also want to know
GNCA's Annual Growth Rates GNCA's Profitability Ratios GNCA's Asset Turnover Ratio GNCA's Dividend Growth
GNCA's Roe GNCA's Valuation Ratios GNCA's Financial Strength Ratios GNCA's Dividend Payout Ratio
GNCA's Roa GNCA's Inventory Turnover Ratio GNCA's Growth Rates GNCA's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2020
Quidel Corp  65.72 %$ 65.724 millions
Chemed Corporation  60.42 %$ 60.420 millions
Tenax Therapeutics Inc   60.40 %$ 60.400 millions
Ensign Group Inc  50.23 %$ 50.230 millions
Innoviva inc   45.90 %$ 45.904 millions
Teva Pharmaceutical Industries Ltd  42.54 %$ 42.537 millions
Nuvasive Inc  40.38 %$ 40.381 millions
Resmed Inc   38.56 %$ 38.555 millions
Medpace Holdings inc   37.11 %$ 37.108 millions
Charles River Laboratories International inc   35.09 %$ 35.089 millions
Alexion Pharmaceuticals Inc   34.58 %$ 34.578 millions
Johnson and Johnson  31.46 %$ 31.456 millions
Bio rad Laboratories Inc   31.39 %$ 31.387 millions
Edwards Lifesciences Corporation  30.60 %$ 30.598 millions
Anika Therapeutics Inc   29.41 %$ 29.405 millions
Zoetis Inc   25.30 %$ 25.296 millions
West Pharmaceutical Services Inc   24.47 %$ 24.470 millions
China Health Industries Holdings Inc   23.94 %$ 23.944 millions
Standard Diversified Inc   23.64 %$ 23.641 millions
Biogen Inc   21.11 %$ 21.109 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MGIC's Profile

Stock Price

MGIC's Financials

Business Description

Fundamentals

Charts & Quotes

MGIC's News

Suppliers

MGIC's Competitors

Customers & Markets

Economic Indicators

MGIC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071